Notice Type
Departmental
Consent to the Distribution of Changed Medicines Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Nicotine 10 mg/ml Solution Kabi Pharmacia Therapeutics AB, Helsinborg, Sweden Nicorette Nasal Spray Beclomethasone dipropionate 100 mcg per actuation Spray (oral metered) Orion Corporation Fermion, Orionintie 1, Espoo, Finland Atomide 100 Inhaler Morphine sulphate 20 mg, 50 mg, 100 mgNote: Not to be marketed as substitutable for any other morphine sulphate product as if the two (2) products were bioequivalent. Capsules (sustained release) Faulding Pharmaceuticals, Salisbury South, South Australia, Australia Kapanol Tenoxicam 20 mg Tablet F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil Tenoxicam 20 mg Suppository F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil Tenoxicam 20 mg Powder for solution (milk) F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil Tenoxicam 20 mg Tablet (effervescent) F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil Tenoxicam 20 mg Tablet F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil Tenoxicam 20 mg Suppository F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil Tenoxicam 20 mg Powder for solution (milk) F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil Tenoxicam 20 mg Tablet (effervescent) F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil Tenoxicam 20 mg Powder for injection (glass vial and diluent) F Hoffmann-La Roche Limited, Basle, Switzerland Tilcotil Diclofenac sodium 0.1% w/v Eye drops Ciba Vision AG, Hettlingen, Switzerland Voltaren Ophtha Verapamil hydrochloride 120 mg, 240 mg Tablets (sustained release) Knoll AG, Ludwigshafen, Germany Isoptin SR Famotidine 10 mg Tablet Merck Sharp & Dohme Limited, Cramlington, Northumber-land, England Pepcid AC Apraclonidine hydrochloride 5.75 mg equivalent to apraclonidine base 5 mg per ml Ophthalmic solution Alcon Laboratories Inc., Fort Worth, Texas, United States of America and S A Alcon Couvreur N V, Puurs, Belgium Iopidine 0.5% Solution Dated this 2nd day of September 1994. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
Publication Date
8 Sep 1994

Notice Number

1994-go6642

Page Number

2783